Post Mortem Tissue Donation of Pediatric Tumor Tissues and Cells

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorAnn & Robert H Lurie Children's Hospital of Chicago

About this trial

The objective of this study is to utilize all donated pediatric tumor tissues and cells obtained from autopsy to prospectively develop novel patient derived orthotopic xenograft (PDOX) mouse models as well as in vitro cell culture model systems for pediatric cancers, and also provide tissue samples to other researchers and organizations (eg, CBTN, DIPG Registry, COG).

Eligibility criteria

Qualifiers

Pediatric patients with cancer and non-cancer tumor types (solid, liquid, neuro-oncology)

Signed consent for post mortem tissue donation and autopsy

Disqualifiers

Signed consent for post mortem tissue donation and autopsy not obtained

Trial design

Treatments tested in this trial

  • Collection of post mortem tissue donation

Treatment groups

150 Participants
are divided into 1 treatment group